Posters
Glomerular Diseases: Practice and New Concepts Shaping Modern Care
October 23, 2026 | 10:00 AM - 12:00 PM
Location: Exhibit Hall A, Convention Center
Session Description
Poster Session
Posters
Efficacy and Safety of Rituximab (RTX) Combined with Glucocorticoids (GC) in Patients with Primary Membranous Nephropathy (PMN)
B-Cell-Activating Factor Ligand-Based Chimeric Antigen Receptor-T Cells Preferentially Deplete Plasmablasts and Transitional B Cells While Preserving Naïve B Cells in Membranous Nephropathy
Antigen-Specific Differences in Membranous Nephropathy: Lower Response and Higher Relapse Rates in Phospholipase A2 Receptor (PLA2R)-Associated Disease
Spontaneous Remission Is Rare in Patients with Phospholipase A2 Receptor (PLA2R)-Associated Membranous Nephropathy
Occurrence and Clinical Effect of Obinutuzumab Antibodies in Patients with Membranous Nephropathy Treated with Obinutuzumab
Maintenance Regimens of Rituximab for Primary Membranous Nephropathy: A Single-Center Retrospective Analysis of 558 Patients
Membranous Nephropathy in Pediatric Patients: Characterization and Long-Term Outcomes of the CureGN Cohort
Efficacy and Kidney Outcomes of Anti-CD20 Monoclonal Antibody Therapy in Patients with Membranous Nephropathy and Concomitant Diabetic Kidney Disease: A Multicenter Cohort Study
Is Antibody Clearance Enough? Immunologic Remission Frequently Fails to Translate into Proteinuria Resolution in Phospholipase A2 Receptor (PLA2R)-Associated Membranous Nephropathy
NELL-1 Membranous Nephropathy Is Associated with HLA-DRB1*13: A Pilot Study of 10 Patients
Patient-Derived Anti-HTRA1 Antibody Discovery Using Purified IgG Mass Spectrometry and B-Cell Receptor Sequencing in Membranous Nephropathy
Early B-Cell Return in Patients with Autoimmune Disease Treated with Rituximab
Cancer-Associated Membranous Nephropathy: A 30-Year Single-Center Cohort Study
Evaluation of Time-Resolved Fluoroimmunoassay (TRFIA) in Detecting Low-Titer Phospholipase A2 Receptor (PLA2R) Antibodies in Patients with Primary Membranous Nephropathy
Rituximab Response Patterns: Podocytopathies Compared with Membranous Nephropathy
Mercury-Associated NELL-1 Membranous Nephropathy: A Case Report and Systematic Review
Sex-Specific Presentation and Response to Long-Term Rituximab in Phospholipase A2 Receptor (PLA2R)-Positive Membranous Nephropathy
Exostosin 1 (EXT1) Expression in Lupus Membranous Nephropathy: Prevalence, Clinicopathological Correlations, and Kidney Outcomes
Use of Rituximab in the Treatment of Nephrotic Glomerulonephritis (TURING): Effect of Achieved Remission Status on the Risk of Relapse
A B-Cell-Targeted Approach to Steroid-Resistant Nephrotic Syndrome in Children
Selective T-Cell Engagement for Deep B-Cell Depletion in Primary Membranous Nephropathy (pMN): Scientific Rationale and Trial Design for CLEAR-AbKD
Subtyping in Patients with Glomerular Disease by eGFR and Urine Protein-to-Creatinine Ratio (UPCR)
Beyond the Dose: Establishing Optimal Mycophenolate Therapeutic Drug Monitoring Targets for Nephrotic Syndrome in Children
Effect of Clinical Remission on Major Adverse Kidney Outcomes in Older Adults with Glomerular Diseases
Kidney Involvement as an Extraintestinal Manifestation in Inflammatory Bowel Disease: A Population-Based Multicentre Retrospective Study
Biomarker Characterization of Treatment-Resistant Minimal Change Disease (TR MCD)
Factors Associated with Sustained Remission of Nephrotic Syndrome in Children
Implementation of PATHWAY GN: Cohort Characterization and Early Transitional Care Outcomes in a Registry-Enabled Glomerular Disease Program
Beyond Clinical Remission: Insights from Protocol Repeat Kidney Biopsies in a Mexican Cohort
The Age Transition for People with Glomerular Diseases: Reflections of Young Adults
Association of Nephrotic Syndrome Disease Activity with Thromboembolism in the CureGN and NEPTUNE Cohorts
Patients with Atypical Hemolytic Uremic Syndrome and Intensive Care Unit Support: Analysis of a Ravulizumab Phase 3 Study
Long-Term Remission Off Therapy in Primary Glomerular Diseases: Insights from Cure Glomerulonephropathy (CureGN)
Mycophenolate Mofetil Modulates Memory B Cells and Plasmablasts Without Persistent Impairment of Immunological Memory in Pediatric Steroid-Sensitive Nephrotic Syndrome
Dyslipidemia Patterns in Proteinuric Glomerular Diseases
Association of Serum and Urinary Fibrinogen with Prognosis and Disease Severity in Patients with IgAN
Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of MIL116, a Novel "Sweeper" Anti-A Proliferation-Inducing Ligand Monoclonal Antibody in Healthy Volunteers: Preliminary Phase 1 Results
Serial Body Weight Does Not Independently Track eGFR or Proteinuria in Primary Glomerular Disease: Longitudinal Findings from CureGN
Rapid Clinical Responses in a Phase 2 Trial of HLX79 (E-602), a First-in-Class Human Sialidase-Fc Fusion Protein, Plus HLX01 (Biosimilar Rituximab) in Membranous Nephropathy
Assessing the Effect of Tacrolimus-Associated Pharmacogenetic Variants on Kidney Function over Time in Nephrotic Syndrome in the NEPTUNE Cohort
Eighteen-Month Effect of Finerenone in Patients with Type 2 Diabetes, CKD, and Nephrotic-Range Proteinuria
Online Continuing Medical Education Bridges the Therapeutic Gap: Enhancing Clinical Readiness for Emerging B-Cell-Modulating Therapies in IgAN Among Nephrologists and Primary Care Providers
Real-World Outcomes of Daratumumab-Based Therapy in AL Amyloidosis with Kidney Involvement: Predictors of Mortality, Kidney Disease Progression, and Survival
Implementation of the First National Dedicated Glomerular Diseases Clinic in Kuwait: Early Real-World Experience from a Tertiary Center in the Middle East and North Africa (MENA) Region
Circulating Propeptide of Type VI Collagen (PRO-C6) Provides Independent Prognostic Information and Identifies Fibrotic Disease Activity Even in Low-Risk IgAN Patients
KDIGO Spoke, Nephrologists Listened: Treatment Paradigms Are Already Shifting
Effect of Different Stages of Cardiovascular-Kidney-Metabolic Syndrome on the Prognosis of Patients with IgA Nephropathy
Identification of Urinary Renal Tubular Epithelial Cell Casts in Proteinuric Glomerular Diseases
Identification of Urinary Vacuolar Casts Is Associated with Worse Kidney Prognosis
Identification of Apolipoprotein C-III (ApoC3) as a Novel Serum Biomarker in Patients with Lupus Nephritis
Proteomic Identification of Serum Effectors of Neutrophil Activation in Lupus Nephritis
Biopsy-Proven Renal Thrombotic Microangiopathy: A Large Middle Eastern Case Series
Real-World Treatment Patterns and Clinical Response Among US Patients with C3 Glomerulopathy (C3G) Receiving Iptacopan: APPRISE-C3G Data Platform
Development and Validation of a Net Benefit Score to Guide Corticosteroid Therapy in IgAN
Efficacy and Safety of Dapagliflozin Combined with RAS Inhibitors in the Treatment of Low-Risk Idiopathic Membranous Nephropathy
Safety of Acute Reduction of Blood Pressure to Enable Performance of a Kidney Biopsy
Mean- vs. Shape-Driven eGFR Trajectories and Relapse Burden
Bartonella Endocarditis Is Strongly Associated with a High Risk for Infection-Related Glomerulonephritis
Shear Wave Elastography in Patients with Acute Glomerulonephritis Compared with a CKD Cohort
Single-Cell Transcriptomics Reveals Stage-Associated CD8+ T-Cell Differentiation Signatures in IgAN